ImmunoHistoChemistry(IHC)
Immunohistochemistry (IHC) is a technique used in histopathology to visualize the presence, localization, and abundance of specific proteins or antigens within tissue samples. It involves the use of antibodies that bind to specific target proteins in tissue sections, followed by detection methods that produce a visual signal indicating the presence of the antigen.
ZETA Corporation
Zeta Corporation, an ISO 13485:2016 certified and FDA registered biomedical company, specialises in providing high-quality, popular IVD antibodies for pathologic diagnosis, guiding cancer treatment, and predicting cancer prognosis. All of their antibodies work on formalin-fixed and paraffin-embedded (FFPE) tissue sections. Zeta Corporation designs and develops tumor-specific biomarkers using cutting-edge technology to uniquely select the immunogens for our famed MonoSpecific monoclonal antibodies (MonoMab™). The IVD Antibodies are carefully tested and validated by NordiQC (Nordic Immunohistochemical Quality Control), an independent Quality Control body. Zeta’s MonoMab™ Antibodies are produced through hybridoma and recombinant technologies.
BIO - SB INC
This US-based company started in 1998. Bio SB performs R&D, production, distribution and marketing of unique products for Immunohistochemistry (IHC), Immunocytochemistry (ICC), Fluorescent in situ hybridization (FISH), Chromogenic in situ hybridization (CISH) and Polymerase Chain Reaction (PCR) technologies that meet the highest international standards for applications in Molecular Pathology, Cancer Research, Microbiology, Immunology and Genetics. Bio SB manufactures and develops products in accordance with FDA QSR 21 CFR Part 820 cGMP and ISO 13485:2003 standards. These guidelines enable them to produce an IVD product that meets the highest in-vitro diagnostic standards. We help their range grow at a fast pace across India.